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Clarification may be required with respect to 
(1) the ethical grounds of providing additional protection to pregnant women and 
(2) what constitutes additional protection to them.
Are there any problems with the 
autonomy of pregnant women?
An autonomous person must have decisional 
capacity and his/her voluntariness must be secured. 
The Belmont Report stipulates that those with 
“diminished autonomy are entitled to protection”.  
This may apply to children (45 CFR 46 Subpart D) due 
to their inadequate capacity and to prisoners (45 CFR 
46 Subpart C) due to their plausible lack of 
voluntariness. Physically or mentally disabled persons, 
and economically or educationally disadvantaged 
persons (46.107, 47.111) are also referred to as 
vulnerable populations in the US Common Rule. 
Coleman points out that it is not clear why certain 
populations, such as pregnant women, are deemed 
deficient in decisional capacity or voluntariness (2009). 
Specifically regarding pregnant women’s decisional 
capacity, the Committee on the Ethical and Legal 
Issues Relating to the Inclusion of Women in Clinical 
Studies (US) has clarified that pregnant women are 
capable of making their own decisions (Mastroianni et 
al. 1994). A similar view is expressed by the American 
College of Obstetricians and Gynecologists (2007). 
Beneficence regarding the fetus
Fetuses require special protection as they are not 
autonomous agents. It may be the responsibility not only 
of pregnant women, but also of healthcare professionals 
and society to protect the fetus’ well-being. For the 
ethical design and conduct of research involving pregnant 
women, McCullough et al. argue that a fetus should be 
recognized as a patient, and that maternal and fetal 
interests must be balanced against each other (2005, 
2008). However, the view of the fetus as a (fully distinct)
patient remains controversial. 
In relation to the fetus, pregnant women face a wide 
variety of challenges in making autonomous decisions 
(Kukla et al. 2009). The CIOMS Guidelines express some 
concern about the informed consent process of women 
who live in societies where a woman is (1) expected not 
to express herself, and (2) is considered less important 
than her fetus (Guidelines 16 and 17). In addition to 
physiological changes and anxiety due to pregnancy, 
familial and societal values may undermine a pregnant 
woman’s voluntariness in relation to her fetus. The 
degree of such influences may differ across cultures and 
communities. 
Background
Today, blanket exclusion of pregnant 
women from research participation is not 
endorsed; however, a tendency still 
remains to exclude pregnant women from 
participating in research. This  exclusion 
results  in insufficient data to guide clinical 
practice for pregnant women, and hence 
adds risks to pregnant women and fetuses 
(Lyerly et al. 2007, 2008, 2009; Baylis 2010; 
Goldkind et al. 2010).
The United States (US) Federal 
Regulations classify pregnant women 
together with fetuses and neonates as 
populations requiring additional protection 
(45 CFR 46 Subpart B). 
The Council for International 
Organizations and Medical Sciences 
(CIOMS) Guidelines do not classify 
pregnant women as a vulnerable 
population; however, the CIOMS Guideline 
17 provides certain conditions for their 
research participation.
Arguments regarding pregnant women may pertain to women of 
childbearing potential and lactating women, even if they are not currently 
pregnant, depending on the reasons for additional protection.
